Literature DB >> 6497462

Clinical judgment in rheumatoid arthritis. IV. Rheumatologists' assessments of disease remain stable over long periods.

J R Kirwan, H L Currey.   

Abstract

Seven rheumatologists made judgments about the improvement or deterioration of identical sets of 50 'paper' patients on two occasions one year apart. The stability of their judgments over one year (rs = 0.70) compared favourably with the reliability of duplicate judgments on each occasion (rs = 0.76). Multiple regression analysis of the patient data in relation to the disease assessments provided a model of each clinician's underlying judgment policy. The stability of judgments predicted by these policy models was even higher (rs = 0.83).

Entities:  

Mesh:

Year:  1984        PMID: 6497462      PMCID: PMC1001510          DOI: 10.1136/ard.43.5.695

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Clinical judgement analysis--practical application in rheumatoid arthritis.

Authors:  J R Kirwan; D M Chaput De Saintonge; C R Joyce; H L Currey
Journal:  Br J Rheumatol       Date:  1983-08

2.  Improving clinical judgement.

Authors:  C R Joyce; K R Hammond
Journal:  Br J Rheumatol       Date:  1983-08

3.  Judging "current disease activity" in rheumatoid arthritis--an international comparison.

Authors:  J R Kirwan; N Bellamy; H Condon; W W Buchanan; C G Barnes
Journal:  J Rheumatol       Date:  1983-12       Impact factor: 4.666

4.  Clinical judgment in rheumatoid arthritis. I. Rheumatologists' opinions and the development of 'paper patients'.

Authors:  J R Kirwan; D M Chaput de Saintonge; C R Joyce; H L Currey
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

  4 in total
  2 in total

1.  Inability of rheumatologists to describe their true policies for assessing rheumatoid arthritis.

Authors:  J R Kirwan; D M Chaput de Saintonge; C R Joyce; J Holmes; H L Currey
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

2.  How can we design trials to detect clinically important changes in disease severity?

Authors:  D M Chaput de Saintonge; J R Kirwan; S J Evans; G J Crane
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.